Immunopathogenic behaviors of canine transmissible venereal tumor in dogs following an immunotherapy using dendritic/tumor cell hybrid

Veterinary Immunology and Immunopathology

Volumn 139, Issue 2-4, 2011, Pages 187-199

  Pai, Chien Chun ^a   Kuo, Tzong Fu ^a   Mao, Simon J T ^b   Chuang, Tien Fu ^a   Lin, Chen Si ^a   Chu, Rea Min ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

Bone marrow derived dendritic cells (BMDCs); Canine transmissible venereal tumor (CTVT); Tumor vaccine

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; DENDRITIC CELL VACCINE; GLYCOPROTEIN P 15095; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T6 ANTIGEN; TUMOR CELL VACCINE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL VENEREAL TUMOR; ARTICLE; BLOOD CHEMISTRY; BODY TEMPERATURE; CANCER IMMUNOTHERAPY; CANINE TRANSMISSIBLE VENEREAL TUMOR; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CYTOTOXICITY; DOG; EXPERIMENTAL MODEL; FEMALE; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INGUINAL LYMPH NODE; LYMPHOCYTIC INFILTRATION; MALE; MIXED LYMPHOCYTE REACTION; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; TUMOR GROWTH; VACCINATION;

ANIMALS; CANCER VACCINES; DENDRITIC CELLS; DOG DISEASES; DOGS; FEMALE; HYBRID CELLS; MACROPHAGES; MALE; VENEREAL TUMORS, VETERINARY;

CANIS FAMILIARIS;

EID: 78650908661     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2010.10.013     Document Type: Article

References (37)

1. Ahrar K., Gowda A., Javadi S., Borne A., Fox M., McNichols R., Ahrar J.U., Stephens C., Stafford R.J. Preclinical assessment of a 980-nm diode laser ablation system in a large animal tumor model. J. Vasc. Interv. Radiol. 2010, 21:555-561.
2. Archbold J.K., Macdonald W.A., Burrows S.R., Rossjohn J., McCluskey J. T-cell allorecognition: a case of mistaken identity or deja vu?. Trends Immunol. 2008, 29:220-226.
3. Avigan D., Vasir B., Gong J., Borges V., Wu Z., Uhl L., Atkins M., Mier J., McDermott D., Smith T., Giallambardo N., Stone C., Schadt K., Dolgoff J., Tetreault J.C., Villarroel M., Kufe D. Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses. Clin. Cancer Res. 2004, 10:4699-4708.
4. Avigan D.E., Vasir B., George D.J., Oh W.K., Atkins M.B., McDermott D.F., Kantoff P.W., Figlin R.A., Vasconcelles M.J., Xu Y., Kufe D., Bukowski R.M. Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma. J. Immunother. 2007, 30:749-761.
5. Bird R.C., Deinnocentes P., Lenz S., Thacker E.E., Curiel D.T., Smith B.F. An allogeneic hybrid-cell fusion vaccine against canine mammary cancer. Vet. Immunol. Immunopathol. 2008, 123:289-304.
6. Bronden L.B., Eriksen T., Kristensen A.T. Oral malignant melanomas and other head and neck neoplasms in Danish dogs-data from the Danish Veterinary Cancer Registry. Acta Vet. Scand. 2009, 51:54.
7. Casal M., Haskins M. Large animal models and gene therapy. Eur. J. Hum. Genet. 2006, 14:266-272.
8. Chou P.C., Chuang T.F., Jan T.R., Gion H.C., Huang Y.C., Lei H.J., Chen W.Y., Chu R.M. Effects of immunotherapy of IL-6 and IL-15 plasmids on transmissible venereal tumor in beagles. Vet. Immunol. Immunopathol. 2009, 130:25-34.
9. Chuang T.F., Lee S.C., Liao K.W., Hsiao Y.W., Lo C.H., Chiang B.L., Lin X.Z., Tao M.H., Chu R.M. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model. Int. J. Cancer 2009, 125:698-707.
10. Clemente M., Perez-Alenza M.D., Pena L. Metastasis of canine inflammatory versus non-inflammatory mammary tumours. J. Comp. Pathol. 2010, 143:157-163.
11. Dunn G.P., Bruce A.T., Ikeda H., Old L.J., Schreiber R.D. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 2002, 3:991-998.
12. Ferreira E., Gobbi H., Saraiva B.S., Cassali G.D. Columnar cell lesions of the canine mammary gland: pathological features and immunophenotypic analysis. BMC Cancer 2010, 10:61.
13. Gong J., Chen D., Kashiwaba M., Kufe D. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat. Med. 1997, 3:558-561.
14. Haenssle H.A., Krause S.W., Emmert S., Zutt M., Kretschmer L., Schmidberger H., Andreesen R., Soruri A. Hybrid cell vaccination in metastatic melanoma: clinical and immunologic results of a phase I/II study. J. Immunother. 2004, 27:147-155.
15. Hsiao Y.W., Liao K.W., Chung T.F., Liu C.H., Hsu C.D., Chu R.M. Interactions of host IL-6 and IFN-gamma and cancer-derived TGF-beta1 on MHC molecule expression during tumor spontaneous regression. Cancer Immunol. Immunother. 2008, 57:1091-1104.
16. Hsiao Y.W., Liao K.W., Hung S.W., Chu R.M. Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells. Vet. Immunol. Immunopathol. 2002, 87:19-27.
17. Hsiao Y.W., Liao K.W., Hung S.W., Chu R.M. Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-beta 1 and restores the lymphokine-activated killing activity. J. Immunol. 2004, 172:1508-1514.
18. Huang Y.C., Hung S.W., Jan T.R., Liao K.W., Cheng C.H., Wang Y.S., Chu R.M. CD5-low expression lymphocytes in canine peripheral blood show characteristics of natural killer cells. J. Leukoc. Biol. 2008, 84:1501-1510.
19. Isotani M., Katsuma K., Tamura K., Yamada M., Yagihara H., Azakami D., Ono K., Washizu T., Bonkobara M. Efficient generation of canine bone marrow-derived dendritic cells. J. Vet. Med. Sci. 2006, 68:809-814.
20. Joy F., Basak S., Gupta S.K., Das P.J., Ghosh S.K., Ghosh T.C. Compositional correlations in canine genome reflects similarity with human genes. J. Biochem. Mol. Biol. 2006, 39:240-246.
21. Kangasniemi M., McNichols R.J., Bankson J.A., Gowda A., Price R.E., Hazle J.D. Thermal therapy of canine cerebral tumors using a 980nm diode laser with MR temperature-sensitive imaging feedback. Lasers Surg. Med. 2004, 35:41-50.
22. Kennedy J.R., Yang T.J., Allen P.L. Canine transmissible venereal sarcoma: electron microscopic changes with time after transplantation. Br. J. Cancer 1977, 36:375-385.
23. Kennedy L.J., Barnes A., Happ G.M., Quinnell R.J., Bennett D., Angles J.M., Day M.J., Carmichael N., Innes J.F., Isherwood D., Carter S.D., Thomson W., Ollier W.E. Extensive interbreed, but minimal intrabreed, variation of DLA class II alleles and haplotypes in dogs. Tissue Antigens 2002, 59:194-204.
24. Laurin D., Kanitakis J., Bienvenu J., Bardin C., Bernaud J., Lebecque S., Gebuhrer L., Rigal D., Eljaafari A. Allogeneic reaction induces dendritic cell maturation through proinflammatory cytokine secretion. Transplantation 2004, 77:267-275.
25. Liao K.W., Lin Z.Y., Pao H.N., Kam S.Y., Wang F.I., Chu R.M. Identification of canine transmissible venereal tumor cells using in situ polymerase chain reaction and the stable sequence of the long interspersed nuclear element. J. Vet. Diagn. Invest. 2003, 15:399-406.
26. Liu C.C., Wang Y.S., Lin C.Y., Chuang T.F., Liao K.W., Chi K.H., Chen M.F., Chiang H.C., Chu R.M. Transient downregulation of monocyte-derived dendritic-cell differentiation, function, and survival during tumoral progression and regression in an in vivo canine model of transmissible venereal tumor. Cancer Immunol. Immunother. 2008, 57:479-491.
27. Murgia C., Pritchard J.K., Kim S.Y., Fassati A., Weiss R.A. Clonal origin and evolution of a transmissible cancer. Cell 2006, 126:477-487.
28. Schwartz J.A., Shetty A.M., Price R.E., Stafford R.J., Wang J.C., Uthamanthil R.K., Pham K., McNichols R.J., Coleman C.L., Payne J.D. Feasibility study of particle-assisted laser ablation of brain tumors in orthotopic canine model. Cancer Res. 2009, 69:1659-1667.
29. Terme M., Ullrich E., Delahaye N.F., Chaput N., Zitvogel L. Natural killer cell-directed therapies: moving from unexpected results to successful strategies. Nat. Immunol. 2008, 9:486-494.
30. Tsai K.L., Clark L.A., Murphy K.E. Understanding hereditary diseases using the dog and human as companion model systems. Mamm. Genome 2007, 18:444-451.
31. Uva P., Aurisicchio L., Watters J., Loboda A., Kulkarni A., Castle J., Palombo F., Viti V., Mesiti G., Zappulli V., Marconato L., Abramo F., Ciliberto G., Lahm A., La Monica N., de Rinaldis E. Comparative expression pathway analysis of human and canine mammary tumors. BMC Genomics 2009, 10:135.
32. Wagner J.L., Sarmiento U.M., Storb R. Cellular, serological, and molecular polymorphism of the class I and class II loci of the canine major histocompatibility complex. Tissue Antigens 2002, 59:205-210.
33. Wang Y.S., Chi K.H., Chu R.M. Cytokine profiles of canine monocyte-derived dendritic cells as a function of lipopolysaccharide- or tumor necrosis factor-alpha-induced maturation. Vet. Immunol. Immunopathol. 2007, 118:186-198.
34. Wang Y.S., Chi K.H., Liao K.W., Liu C.C., Cheng C.L., Lin Y.C., Cheng C.H., Chu R.M. Characterization of canine monocyte-derived dendritic cells with phenotypic and functional differentiation. Can. J. Vet. Res. 2007, 71:165-174.
35. Yang T.J. Immunobiology of a spontaneously regressive tumor, the canine transmissible venereal sarcoma (review). Anticancer Res. 1988, 8:93-95.
36. Yasuda T., Kamigaki T., Kawasaki K., Nakamura T., Yamamoto M., Kanemitsu K., Takase S., Kuroda D., Kim Y., Ajiki T., Kuroda Y. Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma. Cancer Immunol. Immunother. 2007, 56:1025-1036.
37. Yasuda T., Kamigaki T., Nakamura T., Imanishi T., Hayashi S., Kawasaki K., Takase S., Ajiki T., Kuroda Y. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells. Oncol. Rep. 2006, 16:1317-1324.